Indeed, in our cohort, efficacy of ICI was limited and restricted to a tumor with specific immune TME, in contrast to previous published data.31,32,50 The immune infiltrate does not seem to be dependent on SMARCA4-deficiency itself. Here, SMARCA4 is linked to neoplasm.